To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.

Bill 118 hr 4490, also known as the "Pharmacy Delivery of Controlled Substances Act," aims to make changes to the Controlled Substances Act in order to allow pharmacies to deliver certain controlled substances directly to healthcare practitioners who will be administering them to patients, rather than having to deliver them to the end user. This bill is designed to streamline the process of getting necessary medications to patients in a timely and efficient manner.

The bill would require pharmacies to follow strict guidelines and regulations when delivering controlled substances to administering practitioners, in order to ensure the safety and proper handling of these medications. It also includes provisions for record-keeping and reporting requirements to track the delivery of these substances.

Supporters of the bill argue that allowing pharmacies to deliver controlled substances directly to administering practitioners will help to improve access to necessary medications for patients, particularly those in rural or underserved areas. They also believe that this change will help to reduce the risk of diversion and misuse of these substances. Opponents of the bill have expressed concerns about the potential for abuse and misuse of controlled substances if they are delivered directly to healthcare practitioners. They also worry about the potential for errors in the delivery process that could lead to patient harm. Overall, the Pharmacy Delivery of Controlled Substances Act is a complex piece of legislation that seeks to address the challenges of delivering controlled substances to patients in a safe and efficient manner. It will be important for lawmakers to carefully consider the potential benefits and risks of this bill before making a decision on its passage.